🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Do medicine safety warnings change clinical practice? In her latest editorial, Barbara Mintzes discusses the impact of regulatory safety advisory notices and what could be done to improve their implementation. bit.ly/4asitNK

Is Prescrire overly alarmist about conditional marketing authorisations?📷 vu.fr/UsuR?action=PI…

Prescrire's ratings of new drugs in 2023 Prescrire International , Prescrire ▶️Bravo : 0 % ▶️A real advance: 0 % ▶️Offers an advantage: 8 % ▶️Possibly helpful: 16 % ▶️Nothing new: 60 % ▶️Judgement reserved: 8 % ▶️Not acceptable: 7 % english.prescrire.org/en/81/168/6802…

Starting in 15 minutes! Signup link below

If you missed a talk at Consilium by Aaron Mitchell last Thursday, watch it here: youtu.be/dBj9e70F7_o?si… Kevin Knopf Anne-Pierre Pickaert HealthSense Iva Parvanova Anticancer Fund Eric Low Bishal Gyawali, MD, PhD, FASCO Clare Turnbull- Prof/NHS Dr Martin Kaiser

Geheime #Erstattungsbeträge im #Gesetzentwurf des #Medizinforschungsgesetzes (MFG) - mit MFG assoziieren wir „Mit freundlichen Grüßen, Ihre Pharmaindustrie“ – frei zugänglicher Artikel arznei-telegramm.de/html/2024_04/2…

Have a look at EU Medicines Agency public consultation on guidance document on the identification of personal data and commercially confidential information within the structure of MA application dossier (deadline 28 June) ema.europa.eu/en/documents/o…

14 associations françaises publient leur ordonnance pour une nouvelle politique du médicament. Avec une contribution de Prescrire sur la révision de la législation pharmaceutique européenne.

The EU’s pharmaceutical legislation is undergoing its biggest reform in two decades. Now is the moment for member states to pay particular attention to what consumers need, writes BEUC's @ancelsantos in this blog post. @EU2024BE ⬇️ beuc.eu/blog/what-memb…

Unveröffentlichte Studienergebnisse gefährden die evidenzbasierte Gesundheitsversorgung! cochrane.de/news/unveroeff…

Suppression des notices papier : écoresponsable ou irresponsable ? ➡ prescrire.org/fr/3/31/68107/…

France: La HAS souhaite une réflexion sur la doctrine d’évaluation d'autorisations d’accès précoce pour apprécier l’incertitude, sur le bénéfice clinique du médicament, entourant la demande. has-sante.fr/jcms/p_3525703…

🚨🚨NEW: MSF Access Campaign MSF Access Campaign report: Secrets Cost Lives – Transparency and Access to Medical Products This report outlines why progress towards equity in access to medical products can only be built on the open sharing of information and knowledge - not on secrets 🧵

Revolving door: You are free to influence us “behind the scenes,” FDA tells staff leaving for industry jobs bmj.com/content/386/bm…

International Conference on Deprescribing (September 26-27, 2024, Nantes, France) With interventions by ISDB members (International Society of Drug Bulletins): ➡️WS 7: CBiP-BCFi, Belgium ➡️WS 12: Therapeutics Initiative, Canada

#EUGeneralCourt: The European Commission did not give the public sufficiently wide access to the purchase agreements for #Covid19 vaccines 👉 curia.europa.eu/jcms/jcms/Jo2_…

Join Consilium for another discussion panel on Thursday, 3rd October! ❓ Whistleblowing and Whistleblowers in Medical Research: Thirty Years in the Trenches 📅 Thursday 3rd October, 5pm London Time 🎫 Sign up here: eventbrite.co.uk/e/whistleblowe… In conversation with Dr. Nancy Olivieri

Help save GeBu, the Dutch independent bulletin on medicines! Geneesmiddelenbulletin (GeBu) provides independent and objective information to healthcare professionals in the Netherlands to promote rational pharmacotherapy and the rational use of medical devices